Last reviewed · How we verify

Asthma — Treatment Landscape & Competitive Intelligence

Asthma (Respiratory) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Respiratory 10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Asthma, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Dupixent DUPILUMAB Regeneron Interleukin-4 Receptor alpha Antagonist [EPC] Interleukin-4 receptor subunit alpha 2017-01-01
Nucala MEPOLIZUMAB GSK Interleukin-5 Antagonist [EPC] Interleukin-5 2015-01-01
Incruse Ellipta UMECLIDINIUM Glaxo Grp England Anticholinergic Muscarinic acetylcholine receptor M4 2013-01-01
Breo Ellipta VILANTEROL Glaxo Grp Ltd beta2-Adrenergic Agonist Beta-2 adrenergic receptor 2013-01-01
Arcapta Neohaler INDACATEROL Novartis beta2-Adrenergic Agonist Beta-2 adrenergic receptor 2011-01-01
Arnuity Ellipta FLUTICASONE FUROATE Haleon Us Holdings Corticosteroid Glucocorticoid receptor 2007-01-01
Omnaris Alvesco Takeda Gmbh ciclesonide Glucocorticoid receptor 2006-01-01
Omnaris CICLESONIDE Covis ciclesonide Glucocorticoid receptor 2006-01-01
Spiriva TIOTROPIUM BROMIDE Boehringer Ingelheim Anticholinergic Muscarinic acetylcholine receptor M3 2004-01-01
Accolate ZAFIRLUKAST Strides Pharma Intl Leukotriene Receptor Antagonist [EPC] Cysteinyl leukotriene receptor 1 1996-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 14 drugs in Asthma
  2. Pfizer · 4 drugs in Asthma
  3. Glaxo Grp England · 2 drugs in Asthma
  4. Generic (originally Schering) · 2 drugs in Asthma
  5. Fundacio Privada Mon Clinic Barcelona · 1 drug in Asthma
  6. GSK · 1 drug in Asthma
  7. AstraZeneca K.K. · 1 drug in Asthma
  8. Covis · 1 drug in Asthma
  9. Generic (originally Merck/Upjohn) · 1 drug in Asthma
  10. Generic (originally Upjohn/Pfizer) · 1 drug in Asthma
  11. Generic (originally Merck) · 1 drug in Asthma
  12. Boehringer Ingelheim · 1 drug in Asthma

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Asthma:

Cite this brief

Drug Landscape (2026). Asthma — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/asthma. Accessed 2026-05-15.

Related